Drawing for BEHANCE

USPTO serial 79188461

BEHANCE

Reviewed by CopyMark Law Group

Reg. 5225255Status 709
Filing date
Status date
Registration date
Jun 20, 2017
Examiner
ESTRADA, LINDA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BEHANCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Biological substances, namely, biologically active enzymes and microorganisms of natural or synthetic origin for use in the manufacture of dietetic, nutraceutical, pharmaceutical or dermatological products; chemical substances in the nature of chemical preparations of natural or synthetic origin for the production of dietetic, nutraceutical, pharmaceutical or dermatological products; chemical products, namely, chemical preparations for use in the manufacture of nutraceutical, pharmaceutical or dermatological products; active ingredients, namely, active chemical ingredients for use in the manufacture of dietetic, nutraceutical, pharmaceutical or dermatological productsSECTION 71 - CANCELLED—
005Dietetic products, namely, dietetic foods in the nature of pastas, crackers, and bread adapted for medical use; nutraceutical products, namely, nutraceuticals used as dietary supplements; food supplements for nutritional use; pharmaceutical preparations based on active ingredients for pharmaceutical use for the treatment of various medical conditions, namely, endocrinological conditions as well as other muscular conditions, namely, arthritis; dietetic food supplements containing active chemical ingredients; plant extracts for pharmaceutical use; food additives for pharmaceutical use, namely, glucose and lecithin for medical purposesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 23, 2024INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 12, 2024XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 12, 2024XXCRGENERIC MADRID TRANSACTION CREATED—
Sep 6, 2024INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 5, 2024C71TCANCELLED SECTION 71—
Jun 20, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 13, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 26, 2017XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 26, 2017XXCRGENERIC MADRID TRANSACTION CREATED—
Sep 20, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 20, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 4, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 4, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 1, 2017GPNXNOTIFICATION PROCESSED BY IB—
Mar 15, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 15, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 15, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 22, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 21, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Feb 21, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 21, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 21, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 17, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 15, 2017CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 14, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 24, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 23, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 23, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 5, 2016RFNTREFUSAL PROCESSED BY IB—
Jul 21, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 21, 2016RFRRREFUSAL PROCESSED BY MPU—
Jul 21, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 20, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 14, 2016DOCKASSIGNED TO EXAMINER—
Jul 12, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 8, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 7, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance